Work

Concurrent BCR::ABL1 and SET::NUP214 fusions in blast-phase chronic myeloid leukemia

Year: 2026

Type: article

Study design: Case Report

Source: Cancer Genetics

DOI: 10.1016/j.cancergen.2026.08.008

Authors: Meenakkshy Manoharan, FNU Alnoor, Ping Yang, Catalina Amador-Ortiz, Amer Beitinjaneh, Sangeetha Venugopal, Xiaoqiong Wang, Yi Zhou, Roberto Ruiz-Cordero, Jennifer Chapman, Felipe Novoa, Ellen Madarang, Justin Watts, Justin Taylor

Institutions: University of Miami, Sylvester Comprehensive Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, AstraZeneca, Celgene, Florida Department of Health, Incyte, National Cancer Institute, National Institute of General Medical Sciences, Daiichi Sankyo Europe

Awards: G427533880, G752229251, Understanding mechanisms of BTK inhibitor and degrader resistance in patients with chronic lymphocytic leukemia, The role of XPO1 in nuclear export of RNA

OpenAlex ID: W7204681891

FWCI:

Cites: 10

Cited by:

Related to: